In AD, the association of amyloid plaques (Aβ) deposits and tau neurofibrillary tangles (NFT) with neuroinflammation has been extensively acknowledged [6,7,8,9,10] to the point that immunotherapies have been proposed to ameliorate AD [11]. This evidence concerns the gene MAPT and Alzheimer disease.